Monti Chiara Carla | Technological Networks | Top Researcher Award

Dr. Monti Chiara Carla | Technological Networks | Top Researcher Award

University of Insubria | Italy

Dr. Monti Chiara Carla is an accomplished medical professional with extensive experience in clinical governance, healthcare management, and quality control within Italy’s social-healthcare sector. Since March 2020, she has served as the Medical Director and Quality Control Lead for the RSA Area at KOS Care Srl, overseeing 56 facilities across eight Italian regions with over 6,000 beds. Her work focuses on clinical process optimization, risk management, accreditation, staff training, and the development of innovative healthcare services. Previously, from 2017 to 2020, she held key responsibilities in medical and quality management at KOS Care’s Central Health Directorate for Anni Azzurri Residences, managing 40 facilities and 4,000 beds, where she contributed to ethical clinical pathways, pharmaceutical governance, and healthcare compliance. Dr. Monti also served with the Don Pozzoli Onlus Foundation as Facility Doctor and Supervisory Body Member, and led the HALT2 Study promoted by the European Centre for Disease Prevention and Control, focusing on infection control in long-term care. Earlier in her career, she gained significant clinical experience in geriatric, rehabilitative, and neurological care through roles at several nursing homes including Foscolo, Carducci, and Vivaldi facilities, and in the Department of Plastic, Reconstructive, and Aesthetic Surgery at the Macchi Foundation Hospital in Varese. Her career reflects a strong commitment to advancing patient care quality, medical ethics, and organizational excellence within the healthcare system.

Profiles: Scopus

Featured Publications

"Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson’s Disease Unveiled in Peripheral Blood Mononuclear Cells", ACS Chemical Neuroscience, 2023", 143 Citations by 127 documents 7 Documents 5 h-index.

Ingrid L. Chen | Technological Networks | Best Researcher Award

Dr. Ingrid L. Chen | Technological Networks | Best Researcher Award

The Permanente Medical Group | United States

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Dr. Ingrid L. Chen began her academic journey with a strong foundation in psychology, earning her Bachelor of Science in Psychology from the University of California, San Diego (2007–2010). This early exposure to human behavior and mental health laid the groundwork for her future pursuits in medicine. Her passion for psychiatry was further nurtured at Stony Brook University School of Medicine, where she obtained her Doctor of Medicine (2016–2020), developing a robust understanding of clinical practices and patient-centered care. These formative academic years shaped her interest in integrative approaches to mental health and community-focused care.

PROFESSIONAL ENDEAVORS

Dr. Chen's professional career reflects a commitment to both clinical excellence and community involvement. She completed her Psychiatry Residency at Kaiser Permanente Oakland (2020–2024), serving as Chief Resident and actively participating in the Research Track. Her progression continued as she became an Associate Physician with The Permanente Medical Group and took on leadership responsibilities as Director of Community Engagement in the Psychiatry Residency Program. Dr. Chen has also worked with respected organizations including PAVIR as a Research Associate (2011–2013), Kaplan as an SAT/ACT teacher (2013–2015), and UCSD Moores Cancer Center as a Community Health Specialist (2016–2020), showcasing her interdisciplinary expertise and broad social engagement.

CONTRIBUTIONS AND RESEARCH FOCUS ON TECHNOLOGICAL NETWORKS

Dr. Chen’s scholarly work exemplifies her dedication to advancing psychiatric care through research. Her editorial fellowship project with Academic Psychiatry (2023–2024) explored Psychodynamic Psychopharmacology for Asian American Immigrants, addressing cultural nuances in treatment. She led and contributed to multiple projects during her residency, such as Valproic Acid for Delirium Management, Intravenous Ketamine for Treatment-Resistant Depression, and a demographic trends analysis of psychiatry residency applicants, earning both first and co-authorships in the process. Additionally, she collaborated on a multi-site theater-based webinar series on racial equity at Yale School of Medicine, showcasing innovative, arts-based approaches to mental health advocacy.

IMPACT AND INFLUENCE

Dr. Chen’s work has already begun to influence both academic psychiatry and broader community mental health initiatives. Her focus on Asian American mental health, equity in healthcare education, and person-centered care models aligns with growing global priorities in inclusive psychiatric care. Through her clinical practice, she brings evidence-based, culturally responsive treatments to underserved populations. Her active role as Director of Community Engagement emphasizes her belief in bridging academic psychiatry with real-world community needs.

ACADEMIC CITES AND EDITORIAL ENGAGEMENTS

Dr. Chen’s academic footprint is evident in her editorial roles. She served as an Associate Editor and Reviewer for the American Journal of Psychiatry Residents’ Journal (2021–2023), and most recently as an Editorial Fellow for Academic Psychiatry (2023–2024). Her scholarly contributions include poster presentations, published research, and ongoing collaborative projects. These roles have positioned her as a rising thought leader and voice for equitable mental healthcare and integrative psychiatric practices.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Chen’s legacy is being shaped by her rare combination of clinical insight, research excellence, cultural sensitivity, and advocacy. As she continues her journey as an Associate Physician and community leader, her efforts are expected to yield further innovations in immigrant mental health care, psychopharmacological treatments, and academic psychiatry education. She is poised to be a pivotal figure in transforming psychiatry into a more inclusive, humanistic, and community-responsive discipline.

OTHER SIGNIFICANT HIGHLIGHTS

  • Awards & Recognitions: Winner of several honors including the APA Research Colloquium for Junior Investigators (2023), 2nd Place Poster Award at AMWA Annual Meeting (2021), and APA Foundation Recognition (2022).

  • Board Certification: Certified by the American Board of Psychiatry & Neurology (2024).

  • Communication & Education: Former SAT/ACT instructor demonstrating strong pedagogical skills; highly effective communicator with patients, peers, and public audiences.

NOTABLE PUBLICATIONS

"Association of intravenous ketamine with change in depressive symptoms in a large integrated health care system

  • Author: Li Kevin․J.; Slama Natalie․E.; Chen Ingrid; Lee Catherine; Ridout Samuel; Hamilton Steven․P.; Iturralde Esti
  • Journal: Psychiatry Research
  • Year: 2025